Eli Lilly & Co. (LLY) Social Stream
ELI LILLY & Co (LLY) Price Targets From Analysts
Use the tables below to see what analysts covering ELI LILLY & Co think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 20 | $315 | $193 | $262.24 | $233.73 | 12.2% |
The Trend in the Analyst Price Target
Over the past 90 days, LLY's average price target has gone up $46.83.
LLY reports an average of 6.1% for its upside potential over the past 17 months.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-11 | 20 | 315 | 193 | 262.24 | 239.50 | 9.49% |
| 2021-09-04 | 21 | 315 | 193 | 264.13 | 259.53 | 1.77% |
| 2021-08-28 | 21 | 315 | 190 | 259.37 | 259.75 | -0.15% |
| 2021-08-14 | 21 | 302 | 190 | 257.37 | 264.21 | -2.59% |
| 2021-08-07 | 21 | 302 | 190 | 257.37 | 263.44 | -2.3% |
| 2021-08-05 | 21 | 302 | 190 | 254.89 | 264.19 | -3.52% |
| 2021-08-01 | 20 | 300 | 190 | 240.50 | 243.50 | -1.23% |
| 2021-07-24 | 20 | 300 | 190 | 240.50 | 244.15 | -1.49% |
| 2021-07-17 | 19 | 300 | 190 | 236.68 | 232.46 | 1.82% |
| 2021-07-10 | 19 | 300 | 190 | 236.68 | 234.99 | 0.72% |
| 2021-07-03 | 19 | 300 | 190 | 233.73 | 233.96 | -0.1% |
| 2021-06-26 | 19 | 300 | 190 | 231.78 | 230.22 | 0.68% |
| 2021-06-13 | 19 | 252 | 175 | 215.41 | 224.09 | -3.87% |
| 2021-06-05 | 19 | 252 | 175 | 213.73 | 202.02 | 5.8% |
| 2021-05-22 | 19 | 252 | 175 | 213.41 | 199.88 | 6.77% |
| 2021-05-15 | 19 | 252 | 175 | 213.41 | 196.21 | 8.77% |
| 2021-05-08 | 19 | 255 | 170 | 212.36 | 195.42 | 8.67% |
| 2021-04-25 | 19 | 255 | 170 | 215.88 | 188.72 | 14.39% |
| 2021-04-17 | 18 | 255 | 170 | 215.74 | 189.25 | 14% |
| 2021-04-10 | 18 | 256 | 170 | 215.91 | 184.49 | 17.03% |
| 2021-04-03 | 18 | 256 | 170 | 215.91 | 185.24 | 16.56% |
| 2021-03-20 | 17 | 256 | 170 | 216.73 | 184.29 | 17.6% |
| 2021-03-13 | 17 | 256 | 170 | 216.14 | 208.08 | 3.87% |
| 2021-03-06 | 17 | 256 | 170 | 216.14 | 206.92 | 4.46% |
| 2021-02-27 | 17 | 256 | 170 | 216.14 | 204.89 | 5.49% |
| 2021-02-20 | 17 | 256 | 170 | 216.14 | 200.92 | 7.58% |
| 2021-02-13 | 17 | 256 | 170 | 216.14 | 207.29 | 4.27% |
| 2021-02-06 | 17 | 256 | 170 | 213.79 | 201.77 | 5.96% |
| 2021-01-30 | 18 | 245 | 164 | 204.13 | 207.97 | -1.85% |
| 2021-01-23 | 18 | 227 | 150 | 197.08 | 206.14 | -4.4% |
| 2021-01-16 | 17 | 227 | 146 | 185.88 | 190.77 | -2.56% |
| 2021-01-09 | 17 | 209 | 142 | 176.24 | 166.41 | 5.91% |
| 2021-01-02 | 17 | 209 | 142 | 176.24 | 168.84 | 4.38% |
| 2020-12-26 | 17 | 209 | 142 | 176.24 | 166.66 | 5.75% |
| 2020-12-19 | 17 | 209 | 142 | 173.65 | 171.40 | 1.31% |
| 2020-12-09 | 17 | 200 | 142 | 166.24 | 158.00 | 5.22% |
| 2020-12-07 | 17 | 200 | 142 | 165.88 | 147.42 | 12.52% |
| 2020-11-16 | 15 | 200 | 143 | 168.80 | 140.59 | 20.07% |
| 2020-11-06 | 15 | 200 | 143 | 169.33 | 142.74 | 18.63% |
| 2020-10-28 | 14 | 200 | 143 | 170.71 | 131.31 | 30.01% |
| 2020-09-25 | 13 | 190 | 144 | 172.31 | 150.26 | 14.67% |
| 2020-09-09 | 12 | 190 | 148 | 174.67 | NA | NA% |
| 2020-09-03 | 12 | 190 | 148 | 174.67 | NA | NA% |
| 2020-08-29 | 12 | 190 | 148 | 173.08 | NA | NA% |
| 2020-08-20 | 12 | 190 | 148 | 173.08 | NA | NA% |
| 2020-08-13 | 12 | 190 | 148 | 172.83 | NA | NA% |
| 2020-08-02 | 11 | 190 | 148 | 174.27 | NA | NA% |
| 2020-07-10 | 13 | 190 | 146 | 168.15 | NA | NA% |
| 2020-07-07 | 13 | 190 | 146 | 168.31 | NA | NA% |
| 2020-06-29 | 13 | 190 | 146 | 168.31 | NA | NA% |
| 2020-06-19 | 13 | 190 | 146 | 167.46 | NA | NA% |
| 2020-04-25 | 12 | 186 | 140 | 160.58 | NA | NA% |
LLY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.59 | 5 | 8 | 9 | 0 | 0 | 22 |
The Trend in the Broker Recommendations
LLY's average broker recommendation rating worsened by 0.32 over the prior 13 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The average analyst price target of LLY is higher than 95.75% of all US stocks.
- ELI LILLY & Co's number of analysts covering the stock is greater than 97.34% of Pharmaceutical Products stocks.
- LLY has a higher upside potential (average analyst target price relative to current price) than 10.21% of Pharmaceutical Products stocks.
- The variance in analysts' estimates of LLY is less than 26.91% of all US stocks.
In the Pharmaceutical Products industry, JNJ, SGEN and ZTS are the three stocks most similar to ELI LILLY & Co regarding the price target and analyst recommendation information presented here.
What is the outlook for LLY? Use POWR Ratings for clearer insight into price direction.